Jmt101 drug page Clinical trials

Trials with Jmt101

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
0Countries
354Planned patients

Showing 1–1 of 1

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
Not yet recruiting Phase 3 252 patients NCT07134205

This is a randomized, open-label, multicenter, phase III clinical study. The aim is to evaluate the efficacy of JMT101 in combination with irinotecan in the third-line and beyond treatment of Metastatic Colorectal Cancer.

Oct 2025 – Oct 2028 Interventional
Combined with: IrinotecanRegorafenib